Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery
Disease Category: Rosacea
Trial Information
Eligible research study participants must have facial redness associated with rosacea with few inflammatory lesions.
Study requirements and benefits
- Two office visits (Screening and Treatment) with a board-certified Dermatologist
- One application of an investigational topical gel
- Study-related physical exams, eye exams and rosacea assessments
- Compensation for time and travel
- 12+ hour study Treatment visit
Study restrictions
- No spicy and/or caffeinated foods or drink prior to or during the study Treatment visit
- No topical products 24 hours prior to or during the study Treatment visit
Study Inclusion criteria:
- Male or female 18 years of age or older
- At least moderate facial erythema (redness) with 2 or fewer inflammatory facial lesions
- Willingness to comply with study requirements including 12+ hour Treatment visit
Study Exclusion criteria:
- History of Raynaud’s Syndrome, glaucoma, low blood pressure and/or dizziness when going from sitting to standing, circulatory problems of the hands or feet, brain or heart insufficiency, or depression
- Past vision correction surgery
- Abnormal intraocular pressure
- Past diagnosis of rosacea involving mostly pimples, rosacea associated with the thickening of skin of the nose, or rosacea of the eye
Matt Hanson
DermResearch, Inc.
8140 N. Mopac, Bldg. 3, Suite 120
Austin, TX 78759
Phone: 512-349-9889 ext 107
Fax: 512-349-9559
EMail: mhanson@dermresearch.net
View Google Map
Research Center Information: DermResearch, Inc.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.